Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

CTKB 01.02.2025

SERA-AI Powered Highlights
Date of Upcoming Event:2025-01-16
Name of Upcoming Event:43rd Annual J.P. Morgan Healthcare Conference
Full Press ReleaseSEC FilingsOur CTKB Tweets

About Gravity Analytica

Recent News

  • 01.16.2025 - 43rd Annual J.P. Morgan Healthcare Conference
  • 01.15.2025 - Cytek Biosciences Announces Preliminary Full Year 2024 Revenue Results
  • 01.02.2025 - Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

Recent Filings

  • 01.15.2025 - 8-K Current report
  • 01.15.2025 - EX-99.1 EX-99.1
  • 11.20.2024 - 4 Statement of changes in beneficial ownership of securities

FREMONT, Calif.,Jan. 02, 2025(GLOBE NEWSWIRE) --Cytek Biosciences, Inc.(Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming 43rdAnnualJ.P. Morgan Healthcare ConferenceinSan Francisco, CA.

Cytek management is scheduled to present onThursday, January 16that8:15 a.m. Pacific Time/11:15 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at:investors.cytekbio.com.

AboutCytek Biosciences, Inc.

Cytek Biosciences(Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum ProfilingTM (FSPTM) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s platform includes its core FSP instruments, the Cytek AuroraTM and Northern LightsTM systems and its Cytek Aurora CS cell sorter; the Cytek OrionTM reagent cocktail preparation system; the Enhanced Small ParticleTM (ESPTM) detection technology; the flow cytometer and imaging products under the Amnis®and Guava®brands; and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered inFremont, Californiawith offices and distribution channels across the globe. More information about the company and its products is available atwww.cytekbio.com.

Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use inChinaand theEuropean Union).

Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Northern Lights, Cytek Orion, Enhanced Small Particle, ESP, Amnis and Guava are trademarks ofCytek Biosciences, Inc.

In addition to filings with theSecurities and Exchange Commission(SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X (formerly Twitter) account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek’s website, LinkedIn page, and X account in addition to following itsSECfilings, news releases, public conference calls and webcasts.

Media Contact:Stephanie OlsenLages & Associates(949) 453-8080stephanie@lages.com

Investor Contact:Paul GoodsonHead of Investor RelationsCytek Biosciencespgoodson@cytekbio.com

Primary Logo

Source: Cytek Biosciences, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com